Mitochondrial Dysfunction in Cardiovascular Diseases
International Journal of Molecular Sciences · 23.02.2025 · 26 (5) · 1917
DOI: 10.3390/ijms26051917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.02.2025. Verfasst von Han-Mo Yang. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Mitochondria. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government.
Abstract (Originalsprache)
Mitochondrial dysfunction is increasingly recognized as a central contributor to the pathogenesis of cardiovascular diseases (CVDs), including heart failure, ischemic heart disease, hypertension, and cardiomyopathy. Mitochondria, known as the powerhouses of the cell, play a vital role in maintaining cardiac energy homeostasis, regulating reactive oxygen species (ROS) production and controlling cell death pathways. Dysregulated mitochondrial function results in impaired adenosine triphosphate (ATP) production, excessive ROS generation, and activation of apoptotic and necrotic pathways, collectively driving the progression of CVDs. This review provides a detailed examination of the molecular mechanisms underlying mitochondrial dysfunction in CVDs, including mutations in mitochondrial DNA (mtDNA), defects in oxidative phosphorylation (OXPHOS), and alterations in mitochondrial dynamics (fusion, fission, and mitophagy). Additionally, the role of mitochondrial dysfunction in specific cardiovascular conditions is explored, highlighting its impact on endothelial dysfunction, myocardial remodeling, and arrhythmias. Emerging therapeutic strategies targeting mitochondrial dysfunction, such as mitochondrial antioxidants, metabolic modulators, and gene therapy, are also discussed. By synthesizing recent advances in mitochondrial biology and cardiovascular research, this review aims to enhance understanding of the role of mitochondria in CVDs and identify potential therapeutic targets to improve cardiovascular outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
ORCID-Profile: Han-Mo Yang
Förderung
- National Research Foundation of Korea
- Korean government
Zitieren
APA
Yang, H. M. (2025). Mitochondrial Dysfunction in Cardiovascular Diseases. International Journal of Molecular Sciences, 26(5), 1917. https://doi.org/10.3390/ijms26051917
Vancouver
Yang HM. Mitochondrial Dysfunction in Cardiovascular Diseases. International Journal of Molecular Sciences. 2025;26(5):1917. doi:10.3390/ijms26051917
BibTeX
@article{Yang2025,
author = {Yang, Han-Mo},
title = {Mitochondrial Dysfunction in Cardiovascular Diseases},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {1917},
doi = {10.3390/ijms26051917}
}
EUVIMED